trial · primary record
Pumitamig
Non-Small Cell Lung Cancer (NSCLC)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 750 |
| Primary completion | 2031-10-14 |
| Primary endpoint | Progression-free Survival (PFS) by Blinded Independent Central Review (BICR) according to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 |
| Registry ID | NCT07361510 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:05.086Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07361510
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.